Less Ads, More Data, More Tools Register for FREE

Pin to quick picksICG Enterprise Trust Regulatory News (ICGT)

Share Price Information for ICG Enterprise Trust (ICGT)

Share Price is delayed by 15 minutes
Get Live Data
1,398.00    8.00 (0.58%)
Bid:
1,394.00
Ask:
1,412.00
Spread: 18.00 (1.291%)
Market Cap: £850.76m
ICGT Live PriceLast checked at - London Stock Exchange

Intraday ICG Enterprise Trust Share Chart

Interim Management Statement

19 May 2010 10:19

RNS Number : 1832M
Graphite Enterprise Trust PLC
19 May 2010
 



GRAPHITE ENTERPRISE TRUST PLC

 

INTERIM MANAGEMENT STATEMENT

QUARTER ENDED 31 MARCH 2010

 

Graphite Enterprise Trust PLC ('Graphite Enterprise' or 'the Company') presents its Interim Management Statement for the quarter ended 31 March 2010. This is the Company's first Interim Management Statement for its current financial year, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.

 

Investment objective

The objective of Graphite Enterprise is to provide shareholders with long term capital growth through investment in unquoted companies, mostly through specialist funds but also directly.

 

Unaudited net asset value

In the three months to 31 March 2010 the unaudited net asset value per share fell by 1.1p or 0.2% to 463.0p.

 

The value of the investment portfolio increased by £1.1 million in the period and after adjusting for expenses and other movements, the net asset value before the accrual for the dividend for the year to December 2009 rose by £0.8 million.

 

The cost of the dividend was £1.6 million and after accounting for this the net asset value for the quarter fell by £0.8 million.

 

Share price and discount

The share price increased by 4.9% to 320.0p in the period. This compares with an increase of 5.4% in the FTSE All-Share Index. The rise in the share price reflected the narrowing of the discount to the net asset value per share from 34.3% to 30.9%.

 

The investment portfolio

The investment portfolio has been valued using the latest available managers' reports. As March valuations covering only 13.2% of the portfolio had been received by the cut-off date of 6 May, the majority of the portfolio has been valued using managers' reports as at 31 December.

 

Based on these figures, the underlying value of the portfolio in local currencies fell by 0.2% in the quarter. As rises in the euro and the US dollar against sterling increased the sterling value of the portfolio by 0.7%, the portfolio rose by a net 0.5% in the period.

 

Cash flows

In the three months to 31 March 2010, cash balances fell by £6.9 million from £114.0 million to £107.1 million. A total £12.3 million was invested in the period and £5.6 million of proceeds were received from the investment portfolio.

  

Balance sheet and commitments

The summary balance sheet as at 31 March 2010 is set out below:

 

£m

% of total assets

Total portfolio

239.0

69.5%

Cash and cash equivalents

107.1

31.2%

Net debtors/creditors

(2.3)

(0.7%)

Total assets

343.8

100.0%

Net asset value per share

463.0p

 

Outstanding commitments fell by £15.9 million or by 6.5% to £227.3 million during the period. Drawdowns of commitments to funds accounted for £12.3 million of the fall and the release of a commitment for a further £9.1 million. The commitment release did not have any impact on the net asset value in the quarter. These reductions were partially offset by a new commitment of £3.0 million and by the impact of exchange rate movements.

 

The level of overcommitment, being the amount by which commitments exceed cash and near cash, fell by £7.3 million to £122.5 million. This was equivalent to 35.6% of total assets at 31 March 2010.

 

Recent events

The Directors are not aware of any events or transactions which have taken place between 31 March 2010 and the date of publication of this statement which have had a material effect on the financial position of the company.

 

Change of accounting reference date

The Company is required to report its interim results within 60 days of the half year and to provide shorter updates within approximately 50 days of the ends of the first and third quarters. As valuation reports from private equity fund managers covering these periods often arrive after these reporting deadlines, the net asset values released at the half year and at the first and third quarters are often based on relatively out of date information.

 

The Board has therefore decided to change the Company's year end from 31 December to 31 January. This change of accounting reference date and the resultant changes to the half year and quarterly reporting dates, should ensure that future reports are based on more up to date information.

 

The next annual report and accounts will cover the thirteen month period from 31 December 2009 to 31 January 2011. The Company will publish its results for the six months to 30 June 2010 in mid to late July and will also release a more detailed set of results covering the seven months to 31 July 2010 towards the end of September. The Company's second Interim Management Statement for the current financial year will cover the three month period to 31 October 2010 and will be released in early December.

 

This information has not been audited or reviewed by the Company's auditors.

 

Enquires:

Stephen Cavell

Tim Spence

0207 825 5300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMMGMKLLRGGZG
Date   Source Headline
2nd Jun 20269:28 amBUSReducing management fee cap by 20% over two years to 1.00% of NAV
1st Jun 20267:00 amBUSVoting Rights and Capital
27th May 20267:00 amBUSTransaction in Own Shares
26th May 20267:00 amBUSTransaction in Own Shares
22nd May 20267:00 amBUSTransaction in Own Shares
21st May 20267:00 amBUSTransaction in Own Shares
20th May 20267:00 amBUSTransaction in Own Shares
19th May 20265:01 pmBUSAnnual Report and Accounts
19th May 20267:00 amBUSTransaction in Own Shares
18th May 20267:00 amBUSTransaction in Own Shares
15th May 20267:00 amBUSTransaction in Own Shares
14th May 20262:42 pmRNS-RQuotedData's In The HotSeat
14th May 20267:00 amBUSTransaction in Own Shares
12th May 20267:00 amBUSTransaction in Own Shares
11th May 20267:00 amBUSTransaction in Own Shares
7th May 20267:00 amBUSTransaction in Own Shares
7th May 20267:00 amBUSPreliminary Results for the twelve months ended 31 January 2026
5th May 20267:00 amBUSTransaction in Own Shares
1st May 20267:00 amBUSTransaction in Own Shares
1st May 20267:00 amBUSVoting Rights and Capital
27th Apr 20267:00 amBUSTransaction in Own Shares
24th Apr 20267:00 amBUSNotification of Share Transaction
21st Apr 20267:00 amBUSTransaction in Own Shares
20th Apr 20267:00 amBUSTransaction in Own Shares
17th Apr 20267:00 amBUSTransaction in Own Shares
16th Apr 20267:00 amBUSTransaction in Own Shares
15th Apr 20267:00 amBUSTransaction in Own Shares
7th Apr 20264:00 pmBUSDirector/PDMR Shareholding
2nd Apr 202612:34 pmBUSDirector/PDMR Shareholding
1st Apr 20267:00 amBUSVoting Rights and Capital
31st Mar 20267:00 amBUSTransaction in Own Shares
25th Mar 20267:00 amBUSTransaction in Own Shares
20th Mar 20267:00 amBUSTransaction in Own Shares
17th Mar 20261:34 pmBUSDirector/PDMR Shareholding
13th Mar 202612:45 pmRNS-RHardman & Co Research: Shareholder seminar 2026: resilience and growth
12th Mar 20267:00 amBUSDirector/PDMR Shareholding
4th Mar 20267:00 amBUSTransaction in Own Shares
2nd Mar 20267:00 amBUSTransaction in Own Shares
2nd Mar 20267:00 amBUSVoting Rights and Capital
27th Feb 20267:00 amGNWTransaction in Own Shares
26th Feb 20267:00 amGNWTransaction in Own Shares
25th Feb 20267:00 amGNWTransaction in Own Shares
24th Feb 20267:00 amGNWTransaction in Own Shares
23rd Feb 20267:00 amGNWTransaction in Own Shares
20th Feb 20267:00 amGNWTransaction in Own Shares
19th Feb 20267:00 amGNWTransaction in Own Shares
18th Feb 20267:00 amGNWTransaction in Own Shares
17th Feb 20267:00 amGNWTransaction in Own Shares
16th Feb 20267:00 amGNWTransaction in Own Shares
13th Feb 202611:43 amGNWTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.